Annie Rasmussen
Director/Board Member at North Star Group A/S
Annie Rasmussen active positions
Companies | Position | Start | End |
---|---|---|---|
North Star Group A/S | Director/Board Member | - | - |
Career history of Annie Rasmussen
Former positions of Annie Rasmussen
Companies | Position | Start | End |
---|---|---|---|
TOPOTARGET A/S | Founder | 01/01/2000 | 01/01/2008 |
Corporate Officer/Principal | 01/01/2000 | 01/01/2008 | |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Corporate Officer/Principal | - | - |
Danish Oncology Nursing Society | President | - | - |
SCANDION ONCOLOGY A/S | Director/Board Member | 01/01/2020 | - |
Chief Tech/Sci/R&D Officer | 01/01/2020 | - | |
Cancer Guides Denmark
Cancer Guides Denmark Hospital/Nursing ManagementHealth Services Cancer Guides Denmark operates a hospital for cancer treatment. The private company is based in Hellerup, Denmark. The Danish company was founded by Annie Rasmussen. | Founder | 01/01/2009 | - |
Health Creation Denmark | Founder | 01/01/2007 | - |
Medical Prognosis Institute A/S
Medical Prognosis Institute A/S BiotechnologyHealth Technology Medical Prognosis Institute A/S engages in the research and development of drugs and treatments for cancer and other related illnesses. It operates through the following segments: X Labs, Predict, Ventures, Personal, and Diagnostic business areas. The X Labs business area offers invent, prototype, and prove relevant techniques, scientific methodologies and business models. The Predict business area utilize the method to generate drug and patient response reports. The Ventures business area focuses on business development ventures. The Personal business area engages in developing business to consumer products and services. The Diagnostic business area operates lung chip diagnostics. The company was founded by Steen Knudsen in September 2004 and is headquartered in Horsholm, Denmark. | Chief Tech/Sci/R&D Officer | - | - |
Oncology Venture Sweden AB
Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Corporate Officer/Principal | 04/06/2015 | - |
Statistics
International
Denmark | 10 |
Operational
Corporate Officer/Principal | 3 |
Founder | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sectoral
Health Technology | 6 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SCANDION ONCOLOGY A/S | Health Technology |
Private companies | 8 |
---|---|
Topotarget A/S
Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
Medical Prognosis Institute A/S
Medical Prognosis Institute A/S BiotechnologyHealth Technology Medical Prognosis Institute A/S engages in the research and development of drugs and treatments for cancer and other related illnesses. It operates through the following segments: X Labs, Predict, Ventures, Personal, and Diagnostic business areas. The X Labs business area offers invent, prototype, and prove relevant techniques, scientific methodologies and business models. The Predict business area utilize the method to generate drug and patient response reports. The Ventures business area focuses on business development ventures. The Personal business area engages in developing business to consumer products and services. The Diagnostic business area operates lung chip diagnostics. The company was founded by Steen Knudsen in September 2004 and is headquartered in Horsholm, Denmark. | Health Technology |
Oncology Venture Sweden AB
Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Health Technology |
Health Creation Denmark | |
Cancer Guides Denmark
Cancer Guides Denmark Hospital/Nursing ManagementHealth Services Cancer Guides Denmark operates a hospital for cancer treatment. The private company is based in Hellerup, Denmark. The Danish company was founded by Annie Rasmussen. | Health Services |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
North Star Group A/S | |
Danish Oncology Nursing Society |
- Stock Market
- Insiders
- Annie Rasmussen
- Experience